What do European clinical guidelines say about genetic testing for people with neuropsychiatric disorders? A scoping review. [PDF]
Arican I +3 more
europepmc +1 more source
Are neurodegenerative diseases late-onset neurodevelopmental disorders? Tracing the developmental origins of neuronal vulnerability. [PDF]
Cheron J, Ranga A, Bonnefont J.
europepmc +1 more source
Current Pharmacological Management in Juvenile Huntington's Disease.
Robertson L +7 more
europepmc +1 more source
Challenges in Polyglutamine Diseases: From Dysfunctional Neuronal Circuitries to Neuron-Specific CAG Repeat Instability. [PDF]
Deleanu R.
europepmc +1 more source
Dynamic glycosylation remodeling in neurological disorders. [PDF]
Xing D +6 more
europepmc +1 more source
Explore thyself: is it time for metacognition screening in clinical trials? [PDF]
McGarry A +4 more
europepmc +1 more source
Overview of Huntington's Disease and Emerging Treatment Strategies: A Narrative Review. [PDF]
Vega AJ +7 more
europepmc +1 more source
The analysis of schizophrenia-like psychosis in dentatorubral-pallidoluysian atrophy. [PDF]
Ikegami I +6 more
europepmc +1 more source
The 2025 Oligo Meeting in Budapest: Highlights of the 21<sup>st</sup> annual meeting of the oligonucleotide therapeutics society. [PDF]
Godinho BMDC, Guo S.
europepmc +1 more source
A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington's disease. [PDF]
Fernandes JMS +5 more
europepmc +1 more source

